V.P. VOLOSHIN, A.V. EREMIN, S.A. OSHKUKOV

Moscow Regional Clinical Research Institute named after M.F. Vladimirskiy, 61/2 Shepkin Str., Moscow, Russian Federation, 129110

Voloshin V.P. ― D. Med. Sc., Professor, Head of the Department of Traumatology and Orthopedics, tel. (495) 684-53-86, e-mail: viktor_voloshin@mail.ru

Eremin A.V. ― D. Med. Sc., leading researcher of the Department of Traumatology and Orthopedics, tel. (495) 631-74-25, e-mail: eremin_av@mail.ru

Oshkukov S.A. ― junior researcher of the Department of Traumatology and Orthopedics, tel. (495) 631-06-12, e-mail: sergey0687@mail.ru

The results analysis of follow-up of 139 patient with deep prosthesis hip joint infection who have been operated in Moscow Regional Clinical Research Institute named after M.F. Vladimirskiy as of from 1995 to 2015 is present in this article. In 36 cases was applied the one-step surgical treatment with the replacement of the endoprosthesis. In 35 cases was applied the two-step revision arthroplasty with installation of a cement antibiotic-impregnated spacer device. After 3-6 months in the absence of latent infection is carried out repeated endoprosthesis replacement. In 23 cases surgical sanitation with preservation of endoprosthesis components was performed. In 44 cases the permanent removal of the implant is completed with resection arthroplasty with the formation of the iliac-femoral neoarthrosis. The study with follow-up for 10 years gives grounds to believe that the most promising method for the treatment of periprosthetic hip infections is a two-stage revision with the installation of a cement spacer, which allows you to receive 91.4% of favorable results.

Key words: periprosthetic infection, hip joint, surgical sanitation, cement spacer, resection arthroplasty.

REFERENCES

1. Revizionnoe endoprotezirovanie tazobedrennogo sustava, pod red. Devida Dzh. Dzhakovski, Entoni K. Khedli. Perevod s angl. pod red. N.V. Zagorodnego [Revision hip replacement. Ed. by David J. Dzhakovski, Anthony K. Headley. Translated from English. ed. by N.V. Zagorodny]. Moscow: GEOTAR-Media, 2014. 328 p.
2. Parvizi J., Ghanem E., Azzam K. et al. Periprosthetic infection: are current treatment strategies adequate? Acta Orthop. Belg, 2008, 74 (6), pp. 793-800.
3. Voloshin V.P., Eremin A.V., Onoprienko G.A., Lekishvili M.V. Two-stage total hip replacement under deep periprosthetic infection. Vestnik travmatologii i ortopedii, 2012, no. 4, pp. 3-9 (in Russ.).
4. Moskalets O.V., Chuksina Yu.Yu., Eremin A.V. et al. Features of the immune status and immunnokorregiruyuschaya therapy for deep periprosthetic infection of large joints. Rossiyskiy allergologicheskiy zhurnal, 2012, no. 1, pp. 214-216 (in Russ.).
5. Voloshin V.P., Eremin A.V., Zubikov V.S. et al. Place cytology in diagnosis and monitoring of peri-implant inflammation of the large joints. Vestnik travmatologii i ortopedii im. N.N. Priorova, 2013, no. 1, pp. 58-62 (in Russ.).
6. Parvizi J., Gehrke T. Proceedings of the international consensus meeting on periproshetic joint infection. The Journal of Bone & Joint Surgery, 2013, vol. 95-B, no. 11, pp. 1450-1452.
7. Moskalets O.V., Chuksina Yu.Yu., Eremin A.V. et al. Immune therapy correction in patients with infectious and inflammatory complications after arthroplasty of large joints. Rossiyskiy allergologicheskiy zhurnal, 2012, no. 5, pp. 177-178 (in Russ.).